IPO News & Commentary
Get the latest insights on new stocks
- Micro-cap biotech Lakewood-Amedex Biotherapeutics files for a Nasdaq direct listing 01/09/26
- Hair loss biotech Veradermics files for a $100 million IPO 01/09/26
- Electrical distribution equipment manufacturer Forgent Power Solutions files for an estimated $300 million IPO 01/09/26
- Uranium exploration company Jaguar Uranium sets terms for $20 million US IPO 01/09/26
- Budget furniture retailer Bob's Discount Furniture files for an estimated $400 million IPO 01/09/26
- Brazilian mineral exploration company Atlas Critical Minerals prices upsized US IPO at $8, below the range 01/09/26
- Biotech IPOs are back: Why 2026 could mark a hot year for the sector 01/09/26
See more
IPO News By Industry
- US IPO Weekly Recap: December kicks off with 3 notable launches in a week with 7 SPACs 12/05/25
- Hong Kong-based digital marketing firm Cansince Innovations sets terms for $6 million US IPO 12/05/25
- Hong Kong-based digital marketing firm MediaOn Group files and sets terms for a $20 million US IPO 12/03/25
- Uranium exploration company Jaguar Uranium sets terms for $20 million US IPO 01/09/26
- Brazilian mineral exploration company Atlas Critical Minerals prices upsized US IPO at $8, below the range 01/09/26
- Hong Kong recycled construction materials developer GreenVector Holdings files and sets terms for a $10 million US IPO 12/19/25
NYSE IPO News
- Hair loss biotech Veradermics files for a $100 million IPO 01/09/26
- Electrical distribution equipment manufacturer Forgent Power Solutions files for an estimated $300 million IPO 01/09/26
- Budget furniture retailer Bob's Discount Furniture files for an estimated $400 million IPO 01/09/26
- SPAC Black Spade Acquisition III prices $150 million IPO, targeting entertainment and digital assets 01/06/26
- Fleet management software provider Motive Technologies files for a $100 million IPO 12/23/25
Nasdaq IPO News
- US IPO Week Ahead: Markets set for a quiet week after year’s first sizable IPO 01/09/26
- US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO 01/09/26
- Immuno-responsive cancer biotech Eikon Therapeutics files for an estimated $300 million IPO 01/09/26
- Micro-cap biotech Lakewood-Amedex Biotherapeutics files for a Nasdaq direct listing 01/09/26
- Brazilian mineral exploration company Atlas Critical Minerals prices upsized US IPO at $8, below the range 01/09/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: Markets set for a quiet week after year’s first sizable IPO
...read more
US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO
Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings. In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0...read more
Immuno-responsive cancer biotech Eikon Therapeutics files for an estimated $300 million IPO
Eikon Therapeutics, a Phase 2 biotech developing therapies for immuno-responsive cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. However, the deal size is likely a placeholder for an offering that we estimate...read more